This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Trading Volatility; Trouble With Financials

By David Russell of optionMonster

NEW YORK ( TheStreet) -- Below is a compilation of some important stories that ran Monday on optionMONSTER.com. optionMONSTER was co-founded by Deep in the Money Calls author Pete Najarian and uses advanced monitoring systems to detect trading patterns by large institutional traders and retail investors.

Many weapons in volatility trading: Volatility trading is taking off, both in terms of volume and trading vehicles, but choosing your strategy is the key to getting it right.

DRJ says in chaos there is opportunity: Many of you may elect to keep your powder dry, as Jon says, but the opportunities can be amazing for those brave enough to venture into the fray. Case in point: US Airways (LCC).

Mattel (MAT - Get Report) pops along with bullish play: Today's trade is apparently betting that the toy maker has had a pullback within a long-term uptrend and now wants to ride the rally.

Lexmark (LXK - Get Report) buyers adding protection: The computer printer company has been holding up better than most rivals, and now buyers are cautiously adding to positions.

KeyCorp (KEY - Get Report) draws three-way spread: The bank holding company doesn't get much in the way of options volume, but an interesting three-way spread is noteworthy today.

Monday Pre-Market:

Financials hold back full-scale rally: If the financials don't participate on the upside, the upside will be limited. Why they turned red this morning is a bit of a mystery.

Brinks (BCO - Get Report) attracts heavy call buying: The armored-car company has been trapped between $20 and $30 since November 2008, and the bears have driven the stock back to the low end of that range.

Range-bound trade in Bristol-Myers Squibb (BMI - Get Report): The drug company rose Friday after citing "clear evidence" its Apixaban medicine succeeded in reducing the risk of strokes in patients with irregular heartbeats.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BMI $64.04 0.99%
BCO $26.55 -0.52%
LXK $42.99 -0.53%
MAT $29.27 -3.10%
KEY $14.12 -0.74%

Markets

DOW 18,063.93 -16.21 -0.09%
S&P 500 2,113.05 -4.64 -0.22%
NASDAQ 5,069.2950 -22.79 -0.45%

Partners Compare Online Brokers

Free Reports